The effects of desvenlafaxine and paroxetine on the pharmacokinetics of the cytochrome P450 2D6 substrate desipramine in healthy adults.
about
Desvenlafaxine.Desvenlafaxine in the treatment of major depressive disorder.A 10-month, open-label evaluation of desvenlafaxine in outpatients with major depressive disorder.How the Probability and Potential Clinical Significance of Pharmacokinetically Mediated Drug-Drug Interactions Are Assessed in Drug Development: Desvenlafaxine as an Example.Desvenlafaxine succinate: a newer antidepressant for the treatment of depression and somatic symptoms.Desvenlafaxine for major depressive disorder: incremental clinical benefits from a second-generation serotonin-norepinephrine reuptake inhibitor.Clinically significant drug interactions with newer antidepressants.Clinically significant drug interactions with atypical antipsychotics.Desvenlafaxine for the treatment of major depressive disorder.The effect of mirabegron, a potent and selective β3-adrenoceptor agonist, on the pharmacokinetics of CYP2D6 substrates desipramine and metoprolol.Population Pharmacokinetics of Desvenlafaxine: Pharmacokinetics in Korean Versus US Populations.Prediction of drug-drug interactions using physiologically-based pharmacokinetic models of CYP450 modulators included in Simcyp software.Effects of the Proton Pump Inhibitors Omeprazole and Pantoprazole on the Cytochrome P450-Mediated Metabolism of Venlafaxine.
P2860
Q33574492-E663FAA7-5B73-43D0-915B-E343B890BC29Q34234091-49125AAE-6DAA-4336-A433-52EF51AD2CD8Q35252115-31E656E8-C42F-4DCE-8A7F-08276A5149C5Q36028281-BA039087-008C-415C-B940-CD71A95A02C1Q37682552-28C33CCB-DB69-4897-9A0E-15D722DD0D88Q37808483-49822349-9EAB-43B1-A9E4-1A96E7AE3762Q37968621-7AAF02A8-7336-4E5F-A2E3-970D94C287FBQ38156416-13CC010D-E54F-446F-BB6F-101940AE3AE1Q38219037-FCB2D8A1-D554-43F3-B50E-D9C0E03CF594Q46776670-22948434-7E7C-45E0-93CD-4FF19BBA8D73Q47329745-487FEB4A-7627-45F0-BFED-F1ECDF5A2E2CQ47924035-6C28CAA3-C3BA-4374-AD24-F55701B2CAE7Q48129123-423FBED9-CBE0-4170-B102-8843EA5DA07A
P2860
The effects of desvenlafaxine and paroxetine on the pharmacokinetics of the cytochrome P450 2D6 substrate desipramine in healthy adults.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
The effects of desvenlafaxine ...... desipramine in healthy adults.
@en
The effects of desvenlafaxine ...... desipramine in healthy adults.
@nl
type
label
The effects of desvenlafaxine ...... desipramine in healthy adults.
@en
The effects of desvenlafaxine ...... desipramine in healthy adults.
@nl
prefLabel
The effects of desvenlafaxine ...... desipramine in healthy adults.
@en
The effects of desvenlafaxine ...... desipramine in healthy adults.
@nl
P2093
P2860
P356
P1476
The effects of desvenlafaxine ...... desipramine in healthy adults.
@en
P2093
Albena Patroneva
Alice I Nichols
Jeffrey Paul
Jennifer A Isler
Magdy Shenouda
Penny Fatato
Ronald D Pedersen
Saeeduddin Ahmed
P2860
P304
P356
10.1177/0091270008326716
P577
2008-11-11T00:00:00Z